SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-013284
Filing Date
2019-03-11
Accepted
2019-03-11 16:02:22
Documents
2
Period of Report
2019-03-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv515884_3.html 3  
1 OWNERSHIP DOCUMENT tv515884_3.xml 3 1642
2 EXHIBIT 24 tv515884_ex24.htm EX-24 3643
  Complete submission text file 0001144204-19-013284.txt   6805
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 23 BIRCH ROAD MALVERN PA 19355
Business Address
Bernhardt Charles Thomas III (Reporting) CIK: 0001458282 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36598 | Film No.: 19672290